Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.99B |
| 2 |
Eli Lilly
LLY
|
+$3.22B |
| 3 |
UnitedHealth
UNH
|
+$2.21B |
| 4 |
Amazon
AMZN
|
+$2.17B |
| 5 |
Applied Materials
AMAT
|
+$1.87B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$6.48B |
| 2 |
Boeing
BA
|
+$4.34B |
| 3 |
Royal Caribbean
RCL
|
+$2.21B |
| 4 |
Broadcom
AVGO
|
+$1.17B |
| 5 |
Thermo Fisher Scientific
TMO
|
+$1.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.59% |
| 2 | Consumer Discretionary | 12.86% |
| 3 | Healthcare | 12.73% |
| 4 | Industrials | 10.59% |
| 5 | Financials | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
CBIZ
CBZ
$2.96B
| $155M | 0.03% |
2,921,326
-65,633
| -2% | -$4.23M |
|
252
S&P Global
SPGI
$123B
| $154M | 0.03% |
317,060
+1,318
| +0.4% | +$706K |
|
253
Yum! Brands
YUM
$41.4B
| $152M | 0.03% |
1,000,617
+1,442
| +0.1% | +$212K |
|
254
Magnite
MGNI
$3.53B
| $152M | 0.03% |
6,982,861
-5,937,209
| -46% | -$140M |
|
255
Molina Healthcare
MOH
$10.8B
| $152M | 0.03% |
792,786
-1,373,307
| -63% | -$253M |
|
256
Home BancShares
HOMB
$6.26B
| $151M | 0.03% |
5,349,719
-163,428
| -3% | -$4.75M |
|
257
General Mills
GIS
$20.6B
| $151M | 0.03% |
2,985,454
-115,383
| -4% | -$5.79M |
|
258
Alcon
ALC
$35.3B
| $150M | 0.03% |
2,015,585
-68,254
| -3% | -$5.7M |
|
259
CSX Corp
CSX
$93.6B
| $150M | 0.03% |
4,214,472
-5,387,470
| -56% | -$184M |
|
260
ICF International
ICFI
$1.58B
| $149M | 0.03% |
1,607,461
+227,031
| +16% | +$21M |
|
261
Exelon
EXC
$46.9B
| $147M | 0.03% |
3,268,339
+28,968
| +0.9% | +$1.27M |
|
262
Pegasystems
PEGA
$5.24B
| $145M | 0.03% |
2,517,587
-1,455,573
| -37% | -$80.2M |
|
263
Knife River
KNF
$3.79B
| $143M | 0.03% |
1,862,778
-39,966
| -2% | -$3.26M |
|
264
Franco-Nevada
FNV
$44.6B
| $142M | 0.03% |
638,396
+5,361
| +0.8% | +$966K |
|
265
Addus HomeCare
ADUS
$2.2B
| $142M | 0.03% |
1,201,560
+99,262
| +9% | +$11.1M |
|
266
DT Midstream
DTM
$13.8B
| $141M | 0.03% |
1,249,101
+1,743
| +0.1% | +$182K |
|
|
CHYM
267
Chime Financial
CHYM
$12.1B
| $139M | 0.03% |
6,878,057
+3,258,179
| +90% | +$92.6M |
|
268
Marvell Technology
MRVL
$204B
| $138M | 0.03% |
+1,637,881
| New | +$121M |
|
269
BioMarin Pharmaceuticals
BMRN
$13.3B
| $137M | 0.03% |
2,537,596
+2,145,717
| +548% | +$123M |
|
270
Champion Homes
SKY
$5.15B
| $135M | 0.03% |
1,762,378
+19,784
| +1% | +$1.4M |
|
271
Patria Investments
PAX
$1.84B
| $134M | 0.03% |
9,210,843
-511,060
| -5% | -$7.14M |
|
272
Restaurant Brands International
QSR
$26.7B
| $131M | 0.02% |
2,038,745
-552,797
| -21% | -$36.4M |
|
273
PAR Technology
PAR
$758M
| $128M | 0.02% |
3,237,004
+476,839
| +17% | +$26.3M |
|
|
BWIN
274
Baldwin Insurance Group
BWIN
$2.93B
| $127M | 0.02% |
4,513,250
| – | – |
|
275
CNX Resources
CNX
$5.21B
| $127M | 0.02% |
3,950,000
+1,100,000
| +39% | +$33.7M |
|
Similar funds
Capital Research Global Investors's Q3 2025 Portfolio in Review
As of Q3 2025, Capital Research Global Investors held 458 positions worth $533B, up 6.7% from $499B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Capital Research Global Investors's Q3 2025 filing shows 30 new, 198 increased, 163 reduced and 25 closed positions. Its largest new stake was Corning: 11,058,929 shares worth $907M. The largest sale was Meta Platforms (Facebook), an estimated $6.48B.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 29% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Capital Research Global Investors's largest Q3 2025 buy was Corning: 11,058,929 shares worth $907M.
- Capital Research Global Investors added most to NVIDIA in Q3 2025, an estimated $3.99B increase.
- Capital Research Global Investors's biggest Q3 2025 reduction was Meta Platforms (Facebook), cutting an estimated $6.48B.
- Capital Research Global Investors fully exited Ansys in Q3 2025, selling an estimated $984M.
- Capital Research Global Investors's ten largest holdings make up 38% of its $533B portfolio in Q3 2025.
- Capital Research Global Investors opened 30 new positions and closed 25 in Q3 2025.
- Capital Research Global Investors's portfolio value rose 6.7% quarter-over-quarter to $533B.
Based on Capital Research Global Investors's 13F filing for Q3 2025, filed 13 Nov 2025.